The Coronavirus Vaccine, cataloged under National Stock Number 6505-01-723-4643, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Novavax Inc Div Corporate. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Item Name | Coronavirus Vaccine |
| FSC / FSG | 6505 — Drugs and Biologicals (FSG 65) |
| Manufacturers | Novavax Inc Div Corporate (CAGE 1UCZ4) |
| Parameter | Value |
|---|---|
| NSN | 6505-01-723-4643 |
| Primary Part Number | NDC80631-0107-10 |
| Item Name | Coronavirus Vaccine |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Novavax Inc Div Corporate |
| Status | ACTIVE |
| Administration | INJECTION |
| Primary Container Content Quantity | 0.50 MILLILITERS |
| Virus Strain | COVID-19 |
| Primary Container Type | SYRINGE |
| Storage Temp Range | +2.0 TO 8.0 CELSIUS DEGC |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC80631-0107-10 PRIMARY | Novavax Inc Div Corporate (USA) |
| Reference | Meaning |
|---|---|
| 1675884 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM29908 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-723-4643 is a Coronavirus Vaccine, manufactured by Novavax Inc Div Corporate, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-723-4643 has 1 manufacturer part number on file: NDC80631-0107-10 (Novavax Inc Div Corporate).
Key specifications for NDC80631-0107-10: Administration: INJECTION; Primary Container Content Quantity: 0.50 MILLILITERS; Virus Strain: COVID-19; Primary Container Type: SYRINGE. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.